title: Supratherapeutic international normalized ratios in warfarin-treated patients who receive a highly potentiating antimicrobial course.
authors.affiliation: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Daniels
authors.affiliation: Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota.
authors.forename: Jason N
authors.initials: JN
authors.lastname: Barreto
authors.affiliation: Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.
authors.forename: Pritish K
authors.initials: PK
authors.lastname: Tosh
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D014859:Warfarin